Finance

Lists
IRMD:NASDAQ
Iradimed Corp
$84.82
-1.91%
(-1.65) 1D
$84.82
0.00% (0.00)
After hours
Closed: Oct 6, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IRMD...
Open
$87.08
High
$87.08
Low
$84.34
Mkt. cap
1.07B
Avg. vol.
125.14K
Volume
0.00
Dividend
0.94%
Quarterly dividend
$0.20
Ex-dividend date
Aug 14, 2026
P/E ratio
47.36
52-wk high
$107.90
52-wk low
$71.34
EPS
$1.79
Beta
0.88
Shares outstanding
12.79M
No. of employees
166
Open
$87.08
High
$87.08
Low
$84.34
Mkt. cap
1.07B
Avg. vol.
125.14K
Volume
0.00
Dividend
0.94%
Quarterly dividend
$0.20
Ex-dividend date
Aug 14, 2026
P/E ratio
47.36
52-wk high
$107.90
52-wk low
$71.34
EPS
$1.79
Beta
0.88
Shares outstanding
12.79M
No. of employees
166
News stories
From web sources and news partners
About Iradimed Corp
CEO-
Employees166
Founded1992
HeadquartersOrlando, Florida, United States
SectorMedical device
Websiteiradimed.com
Analyst ratings
Based on 2 analysts giving stock ratings to IRMD in the past 3 months
Buy
Buy
1
Hold
1
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for IRMD in the last 3 months.
Highest
Current $84.82
$120.00 (+41.48%)
Average
$120.00 (+41.48%)
Lowest
$120.00 (+41.48%)
Analyst
Recommendation
Action
Price target
Projected
Date
David Saxon
Needham
Hold
Initiated
-
-
09/22/2026
Frank Takkinen
Lake Street
Buy
Reiterated
$120.00
+41.5%
08/03/2026
Ilya Zubkov
Freedom Capital Markets
Buy
Initiated
$116.00
+36.8%
04/02/2026
Kyle Bauser
Roth MKM
Buy
Reiterated
$120.00
+41.5%
02/11/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
21.20M
22.69M
21.98M
20.47M
Cost of goods sold
4.71M
5.66M
5.16M
5.31M
Cost of revenue
4.71M
5.66M
5.16M
5.31M
Research and development expenses
674.36K
775.03K
956.00K
657.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8.99M
9.16M
8.62M
8.11M
Operating expense
9.66M
9.94M
9.58M
8.77M
Total operating expenses
14.37M
15.60M
14.74M
14.08M
Operating income
6.83M
7.09M
7.24M
6.39M
Other non operating income
463.98K
-1.52M
532.00K
497.00K
EBT including unusual items
7.30M
7.79M
7.77M
6.89M
EBT excluding unusual items
7.30M
7.59M
7.77M
6.89M
Income tax expense
1.72M
1.35M
1.95M
1.67M
Effective tax rate
23.58%
17.31%
25.11%
24.25%
Other operating expenses
-
-
-
-
Net income
5.58M
6.44M
5.82M
5.22M
Net profit margin
26.30%
28.39%
26.47%
25.50%
Earnings per share
0.47
0.54
0.49
0.46
Interest and investment income
-
2.01M
-
-
Interest expense
-
-
-
-
Net interest expenses
-
2.01M
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
7.22M
7.47M
7.69M
6.80M
Gain or loss from assets sale
32.99K
2.85K
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps